Table: Sawai Pharmaceutical -Q1 group results

SAWAI group

08/08/2016 07:00

Aug 8 (Reuters)-  
             Sawai Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               32.95               29.39           143.00     
                   (+12.1 pct)         (+17.0 pct)      (+15.8 pct)  
  Operating            5.89                6.35            25.00     
                   (-7.3 pct)          (+26.4 pct)      (+7.8 pct)   
  Recurring            5.91                6.27            24.70     
                   (-5.6 pct)          (+24.6 pct)      (+7.3 pct)   
  Net                  4.36                5.09            18.50     
                   (-14.4 pct)         (+48.1 pct)      (+7.8 pct)   
  EPS              118.19 yen          138.38 yen       501.80 yen   
  EPS Diluted      118.13 yen          138.24 yen                    
  Ann Div                              120.00 yen       130.00 yen   
  -Q2 div                               55.00 yen        65.00 yen   
  -Q4 div                               65.00 yen        65.00 yen   
   
  NOTE - Sawai Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T  
  ((Tokyo Headline News Desk +813 6441 1812))